Literature DB >> 11233238

Platelet activation and aggregation during normothermic cardiopulmonary bypass.

Y Misawa1, H Konishi, K Kawahito, K Fuse.   

Abstract

OBJECTIVE: The usefulness of heparin-bonded circuits under normothermic cardiopulmonary bypass has not been elucidated. We studied platelet activation and aggregation differences between heparin-bonded and nonheparin-bonded circuits in patients undergoing surgery involving normothermic cardiopulmonary bypass.
METHODS: Eight patients underwent coronary artery bypass grafting with non heparin-bonded circuits (controls) and 7 the same with heparin-bonded circuits (heparin group). Heparin bonding was applied to the blood contact surface of our system, including the oxygenator and connecting tubes. Patient body temperature was kept between 36 and 37 degrees C. Beta-thromboglobulin and platelet factor 4 were measured before, during, and after cardiopulmonary bypass, and platelet aggregation was evaluated by laser-light scattering.
RESULTS: Changes in beta-thromboglobulin and platelet factor 4 during and after cardiopulmonary bypass were similar in both groups. Small particle formation was the primary aggregate induced during and after cardiopulmonary bypass in both groups, and serial changes in particle formation up to 24 hours after cardiopulmonary bypass were similar in both groups.
CONCLUSIONS: Our results indicate that in 2-3 hours of normothermic cardiopulmonary bypass, heparin-bonded circuits are similar to nonheparin-bonded ones in platelet compatibility.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11233238     DOI: 10.1007/bf02913119

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  17 in total

1.  Inflammatory response to cardiopulmonary bypass using two different types of heparin-coated extracorporeal circuits.

Authors:  C Baufreton; M Moczar; L Intrator; P G Jansen; H te Velthuis; P Le Besnerais; J P Farcet; C R Wildevuur; D Y Loisance
Journal:  Perfusion       Date:  1998-11       Impact factor: 1.972

2.  The effects of Carmeda Bioactive Surface on human blood components during simulated extracorporeal circulation.

Authors:  R L Korn; C A Fisher; E R Livingston; N Stenach; S J Fishman; V Jeevanadam; V P Addonizio
Journal:  J Thorac Cardiovasc Surg       Date:  1996-05       Impact factor: 5.209

3.  Assessment of the myocardial protective effect of antegrade warm blood cardioplegia by measuring the release of biochemical markers.

Authors:  K Kawahito; J Mohara; Y Misawa; M Kato; K Fuse
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

4.  Heparin-coated cardiopulmonary bypass equipment. II. Mechanisms for reduced complement activation in vivo.

Authors:  V Videm; T E Mollnes; K Bergh; E Fosse; B Mohr; T A Hagve; A O Aasen; J L Svennevig
Journal:  J Thorac Cardiovasc Surg       Date:  1999-04       Impact factor: 5.209

5.  Platelet aggregation during cardiopulmonary bypass evaluated by a laser light-scattering method.

Authors:  K Kawahito; E Kobayashi; H Iwasa; Y Misawa; K Fuse
Journal:  Ann Thorac Surg       Date:  1999-01       Impact factor: 4.330

6.  Release of proinflammatory cytokines during pediatric cardiopulmonary bypass: heparin-bonded versus nonbonded oxygenators.

Authors:  S Ashraf; Y Tian; D Cowan; A Entress; P G Martin; K G Watterson
Journal:  Ann Thorac Surg       Date:  1997-12       Impact factor: 4.330

7.  Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations.

Authors:  V Videm; J L Svennevig; E Fosse; G Semb; A Osterud; T E Mollnes
Journal:  J Thorac Cardiovasc Surg       Date:  1992-04       Impact factor: 5.209

8.  Clinical study of platelet function and coagulation/fibrinolysis with Duraflo II heparin coated cardiopulmonary bypass equipment.

Authors:  T Nakajima; S Osawa; M Ogawa; T Sasaki; H Izumoto; Y Yagi; K Kawazoe
Journal:  ASAIO J       Date:  1996 Jul-Aug       Impact factor: 2.872

9.  Specific complement inhibition with heparin-coated extracorporeal circuits.

Authors:  H te Velthuis; P G Jansen; C E Hack; L Eijsman; C R Wildevuur
Journal:  Ann Thorac Surg       Date:  1996-04       Impact factor: 4.330

10.  Reduced complement activation and improved postoperative performance after cardiopulmonary bypass with heparin-coated circuits.

Authors:  P G Jansen; H te Velthuis; R A Huybregts; R Paulus; E R Bulder; H I van der Spoel; P D Bezemer; E H Slaats; L Eijsman; C R Wildevuur
Journal:  J Thorac Cardiovasc Surg       Date:  1995-09       Impact factor: 5.209

View more
  3 in total

1.  Platelet activation and aggregation during normothermic cardiopulmonary bypass.

Authors:  T Kawada
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-09

2.  The quantitative and qualitative responses of platelets in pediatric patients undergoing cardiopulmonary bypass surgery.

Authors:  Vera Ignjatovic; Jenny Than; Robyn Summerhayes; Fiona Newall; Steve Horton; Andrew Cochrane; Paul Monagle
Journal:  Pediatr Cardiol       Date:  2011-08-02       Impact factor: 1.655

3.  Biocompatibility assessment of a long-term wearable artificial pump-lung in sheep.

Authors:  Kang Zhou; Shuqiong Niu; Giacomo Bianchi; Xufeng Wei; Narayana Garimella; Bartley P Griffith; Zhongjun J Wu
Journal:  Artif Organs       Date:  2013-03-03       Impact factor: 3.094

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.